What are the treatment options for Molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment for molluscum contagiosum should prioritize watchful waiting for mild cases, as the infection often resolves spontaneously within 6-12 months, and cryotherapy with liquid nitrogen or cantharidin for more severe or cosmetically bothersome cases, as these methods have shown similar efficacy in children 1.

Treatment Approaches

  • Watchful waiting is a reasonable approach for mild cases, as resolution of uncomplicated molluscum contagiosum typically occurs spontaneously in 6 to 12 months 1.
  • For active treatment, physical destruction methods such as cryotherapy with liquid nitrogen applied to each lesion for 5-10 seconds, or cantharidin (a blistering agent) applied by a healthcare provider to each lesion and washed off after 2-6 hours, are most common.
  • Topical treatments, including imiquimod, have not shown significant benefit compared to placebo in randomized controlled trials 1.

Considerations

  • Patients with underlying skin conditions, such as eczema, or those with cosmetically bothersome lesions, may benefit from treatment with 10% potassium hydroxide or cryotherapy with liquid nitrogen 1.
  • Imiquimod was not shown to be of benefit compared with placebo in randomized controlled trials 1, and therefore should not be considered a first-line treatment.
  • Cantharidin, although effective in some cases, has limited evidence supporting its use, and its effectiveness was not found to be statistically significant in a small randomized controlled trial 1.

Management

  • During treatment, patients should avoid scratching lesions, cover affected areas during activities with skin-to-skin contact, and avoid sharing towels or personal items to prevent spread.
  • Follow-up is not usually necessary unless the conjunctivitis persists, and referral to a dermatologist may be necessary for examination of other suspicious lesions 1.

From the FDA Drug Label

Imiquimod cream was evaluated in two randomized, vehicle-controlled, double-blind trials involving 702 pediatric subjects with molluscum contagiosum (MC) (470 exposed to imiquimod; median age 5 years, range 2-12 years). These studies failed to demonstrate efficacy

The treatment for molluscum contagiosum with imiquimod cream failed to demonstrate efficacy in two randomized, vehicle-controlled, double-blind trials involving 702 pediatric subjects 2.

  • Key points:
    • Imiquimod cream was evaluated in pediatric subjects with molluscum contagiosum.
    • The studies failed to demonstrate efficacy.
    • The most frequently reported adverse reaction was application site reaction.
  • Clinical decision: Due to the lack of demonstrated efficacy, imiquimod cream should not be considered a reliable treatment option for molluscum contagiosum 2, 2.

From the Research

Treatment Options for Molluscum Contagiosum

  • The need for active treatment for molluscum contagiosum is controversial, but treatment is often indicated in cases of extensive disease, associated complications, or aesthetic complaints 3.
  • Several treatment modalities are available, including mechanical, chemical, immunomodulatory, and antiviral treatments 3.
  • A modified curettage technique has been described as an effective and well-tolerated treatment option for removing lesions of molluscum contagiosum 4.
  • Cantharidin is a treatment option for molluscum contagiosum, which can be applied in a practical approach 5.
  • Other treatment options include destructive therapies (curettage, cryotherapy, keratolytics), immunomodulators (imiquimod, cimetidine, Candida antigen), and antivirals (cidofovir) 5.

Special Considerations for Treatment

  • Treatment approaches for molluscum contagiosum can vary widely, and there are no FDA-approved treatments available 6.
  • Special considerations for treatment include atopic dermatitis, skin of color, and other factors that may affect treatment outcomes 6.
  • Early diagnosis and treatment of molluscum contagiosum are important to reduce the risk of sexual transmission, prevent autoinoculation, and increase patient quality of life 7.
  • Novel patient-administered treatment options are available, which can provide added convenience and reduce patient embarrassment or stress 7.

Treatment Guidelines and Algorithms

  • There is a lack of clinical data from large, well-controlled studies, resulting in significant gaps in knowledge about treatment guidelines and algorithms for molluscum contagiosum 6.
  • A review of treatment approaches and special considerations for molluscum contagiosum can provide practitioners with expert, evidence-based information and guidance 6.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.